Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 W 4th Avenue, Vancouver, Canada

Bastox Sep. 15 at 7:45 PM

$ABCL Wow. 272k share buy

0 · Reply

Stocktradesmoon Sep. 15 at 7:32 PM

$ABCL 🚨REMEMBER Market Conditions are TEMPORARY‼️ 🚨Tomorrow with the Market already pricing in a RATE HIKE and When we don’t have One! BOOM! BOOM!!!!!! $13’sss!! We are going to be SUPER GREEN!! We GOT GREAT NEWS and with Carl Cantor conference Call His Huge Bombshells (NUGGETS)!! We are going to take OFF! $13-$15’sss Coming!!! YOU’re going to be wishing you had BOUGHT in the $11.40’sss Today‼️ We are going to be Opening tomorrow in the Mid-$12’sssss!!! Get in NOW!! Or Regret Missing Out🚨 Read ALL My Posts!! Carl from his own words said Patients WERE “CURED”. Yes‼️ “CURED” Patients went from 10 EVENTS to “ZERO” 😮 😮 🤯

0 · Reply

Bastox Sep. 15 at 7:28 PM

$ABCL They’re pinning on Level Ii

0 · Reply

Bastox Sep. 15 at 7:06 PM

$ABCL Been in with a load from $4.50. Mo mo is a takeover rumor that leaves CEO in charge. Low 20’s takeout.

1 · Reply

Stocktradesmoon Sep. 15 at 6:54 PM

$ABCL Only Reason $ABCL is at a discount right now is because of Market Conditions‼️ It’s still a Monster during the Market being RED! Wait until tomorrow when the FED Keeps the rate the same! BOOM!!! No more discounts! The market already expects a rate HIKE We won’t have one!! Super green tomorrow‼️$12’ssss tomorrow‼️ You’re going to WISH you had Bought 11’ss!!! Today🚨‼️

1 · Reply

Stocktradesmoon Sep. 15 at 6:14 PM

$ABCL

0 · Reply

Money_maker777 Sep. 15 at 6:09 PM

$SPY red, but $ABCL and $RKLB said nah staying green and pushing. Love seeing the outperformance on a shaky market day.

0 · Reply

Money_maker777 Sep. 15 at 6:06 PM

$ABCL LFG the climb back toward $12 is loading.

0 · Reply

Stocktradesmoon Sep. 15 at 6:02 PM

$ABCL GET in NOW!! Beautiful Chart 📈 Wants MUCH..MUCH…HIGHER!‼️ DON’T Regret not getting in! People are coming back from lunch and we are about to take off to $12’ssss! We about to SQUEEZE!!!

1 · Reply

Stocktradesmoon Sep. 15 at 5:56 PM

$ABCL Get READY!! My Chart 📈 just Signaled 12’sss WILL HAPPEN TODAY‼️ The Chart is Consolidating and it’s SCREAMING it wants $14.89-$15.50’ss short term!!

0 · Reply

AbCellera Biologics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

Sep 2, 2026, 4:05 PM EDT - 12 days ago

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

2026-08-25T16:06:05.000Z - 21 days ago

AbCellera rises 17.0%

2026-08-25T14:06:36.000Z - 21 days ago

AbCellera rises 10.7%

Aug 13, 2026, 12:05 AM EDT - 4 weeks ago

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

2026-08-11T20:05:47.000Z - 4 weeks ago

AbCellera announces $200M common stock, warrants offering

Aug 11, 2026, 4:01 PM EDT - 4 weeks ago

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

2026-08-11T13:35:37.000Z - 5 weeks ago

AbCellera price target raised to $30 from $12 at Truist

2026-08-10T19:55:32.000Z - 5 weeks ago

AbCellera price target raised to $25 from $13 at JonesResearch

Aug 10, 2026, 8:00 AM EDT - 5 weeks ago

AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:23 AM EDT - 5 weeks ago

This Biotech's Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.

Aug 10, 2026, 7:13 AM EDT - 5 weeks ago

AbCellera menopause drug cuts hot flashes in mid-stage trial, shares rise

2026-08-10T11:11:27.000Z - 5 weeks ago

AbCellera announces Phase 1/2 trial of ABCL635 met primary efficacy endpoints

Aug 10, 2026, 7:00 AM EDT - 5 weeks ago

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Aug 7, 2026, 4:30 PM EDT - 5 weeks ago

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

2026-08-06T12:20:50.000Z - 5 weeks ago

AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:12:02.000Z - 5 weeks ago

AbCellera price target raised to $12 from $11 at Cantor Fitzgerald

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 4:05 PM EDT - 5 weeks ago

AbCellera Reports Q2 2026 Business Results

2026-07-29T11:27:06.000Z - 6 weeks ago

AbCellera announces collaboration with Vertex Pharmaceuticals

VRTX

Jul 29, 2026, 7:00 AM EDT - 6 weeks ago

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

2026-07-09T21:29:02.000Z - 2 months ago

3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts

NUVB SERV UBER

Jul 7, 2026, 4:05 PM EDT - 2 months ago

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

2026-07-07T10:35:14.000Z - 2 months ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ

2026-07-06T13:15:29.000Z - 2 months ago

AbCellera apponts Lynn Seely to board of directors

LYEL

Jul 6, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jun 17, 2026, 7:43 AM EDT - 3 months ago

Jazz Pharma, AbCellera ink antibody deal worth up to $876 million

JAZZ

Jun 17, 2026, 7:00 AM EDT - 3 months ago

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies

Jun 5, 2026, 9:00 AM EDT - 3 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 4, 2026, 11:40 AM EDT - 3 months ago

AbCellera Biologics Transcript: Jefferies Global Healthcare Conference 2026

May 13, 2026, 8:00 PM EDT - 4 months ago

AbCellera Biologics Transcript: Bank of America Global Healthcare Conference 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Slides: Q1 2026

May 11, 2026, 4:05 PM EDT - 4 months ago

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

May 7, 2026, 4:05 PM EDT - 4 months ago

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing

Apr 21, 2026, 1:30 PM EDT - 4 months ago

AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

Apr 20, 2026, 9:00 AM EDT - 4 months ago

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Apr 1, 2026, 4:05 PM EDT - 5 months ago

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Mar 17, 2026, 4:30 PM EDT - 6 months ago

AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 4, 2026, 9:50 AM EST - 6 months ago

AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results

Feb 11, 2026, 4:05 PM EST - 7 months ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Jan 22, 2026, 4:05 PM EST - 7 months ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 14, 2026, 6:45 PM EST - 8 months ago

AbCellera Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:00 AM EST - 8 months ago

AbCellera Biologics Slides: Corporate presentation

Jan 12, 2026, 9:00 AM EST - 8 months ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Dec 18, 2025, 9:00 AM EST - 9 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 8, 2025, 4:05 PM EST - 9 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 3, 2025, 8:00 AM EST - 9 months ago

AbCellera Biologics Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Sep 29, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 1 year ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 9:00 AM EDT - 1 year ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation

Jul 7, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 9, 2025, 10:40 AM EDT - 1 year ago

AbCellera Biologics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 1:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 1 year ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 1 year ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results

May 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference 2025

Apr 29, 2025, 3:00 PM EDT - 1 year ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing

Apr 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 19, 2025, 1:30 PM EDT - 1 year ago

AbCellera Biologics Transcript: KeyBanc Annual Health Care Forum

Mar 3, 2025, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 3, 2024, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 19, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2024

Nov 18, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Stifel 2024 Healthcare Conference

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Bastox Sep. 15 at 7:45 PM

$ABCL Wow. 272k share buy

0 · Reply

Stocktradesmoon Sep. 15 at 7:32 PM

0 · Reply

Bastox Sep. 15 at 7:28 PM

$ABCL They’re pinning on Level Ii

0 · Reply

Bastox Sep. 15 at 7:06 PM

$ABCL Been in with a load from $4.50. Mo mo is a takeover rumor that leaves CEO in charge. Low 20’s takeout.

1 · Reply

Stocktradesmoon Sep. 15 at 6:54 PM

1 · Reply

Stocktradesmoon Sep. 15 at 6:14 PM

$ABCL

0 · Reply

Money_maker777 Sep. 15 at 6:09 PM

$SPY red, but $ABCL and $RKLB said nah staying green and pushing. Love seeing the outperformance on a shaky market day.

0 · Reply

Money_maker777 Sep. 15 at 6:06 PM

$ABCL LFG the climb back toward $12 is loading.

0 · Reply

Stocktradesmoon Sep. 15 at 6:02 PM

1 · Reply

Stocktradesmoon Sep. 15 at 5:56 PM

$ABCL Get READY!! My Chart 📈 just Signaled 12’sss WILL HAPPEN TODAY‼️ The Chart is Consolidating and it’s SCREAMING it wants $14.89-$15.50’ss short term!!

0 · Reply

Stocktradesmoon Sep. 15 at 5:20 PM

$ABCL Look 👀 Level II. 300,000 BUY JUST NOW‼️❤️ News must be coming after hours or premarket!! $12’sss today!!

0 · Reply

MagicRon_ Sep. 15 at 5:00 PM

$ABCL FFS Elliot Wave theory Boys. The 2nd pulls back before the biggest wave 3 😄👎

2 · Reply

psyxopathis Sep. 15 at 4:57 PM

$ABCL @MagicRon_ does anyone knows if this muppet is alive ? 🤣🤣💦💦💦

1 · Reply

Stocktradesmoon Sep. 15 at 4:46 PM

$ABCL Here COMES 12’sss!!! Who’s ONBOARD with me!!! Let’s GO!!

0 · Reply

snowPOW Sep. 15 at 4:41 PM

$BB not my meme, but golden! $ABCL yesssss

0 · Reply

Stocktradesmoon Sep. 15 at 4:37 PM

$ABCL Here we GO‼️ 12’sss!!!

0 · Reply

Stocktradesmoon Sep. 15 at 4:10 PM

$ABCL GET in NOW!!! We ABOUT to SQUEEZE to $12’sss! BEAUTIFUL CHART 📈!! HUGE BUYS!! CONSOLIDATION DONE ✅! This Chart is SCREAMING $14.89 to $15.50’sss!! This WEEK‼️ We about to JUMP straight to $12’sss! CHART is all COILED UP and ready to SQUEEZE!!!

1 · Reply

ITF Sep. 15 at 4:08 PM

$ABCL MONSTER, let's close over 11.43

0 · Reply

Stocktradesmoon Sep. 15 at 3:50 PM

$ABCL We have had really Great Catalysts as of recent!! Cantor Conference Call with CARL was a HOMRUN! Best 30 minute Call I have EVER LISTENED too! 🚨I’m expecting some more News After hours or Pre-Market. There are Clear signs here and indicators I look 👀 at that tells me something was inked and signed as of recent. They are waiting to release it! Knowing Carl he ❤️’s releasing them on Friday afterhours to trap and burn 🔥 all the SHORTS‼️❣️ I’m so EXCITED 😆! This a Generational BEHEMOTH, POWERHOUSE, and TITAN of a Company in the Making‼️

1 · Reply

DeMampCamp Sep. 15 at 3:41 PM

$ABCL All this baby needs is a catalyst and it's ready to make new highs! Mr. Chad Henson is putting ABCL on the map and we're going places. Hold your shares, add when you can, and let the rest take care of itself! Cheers all!

0 · Reply

Stocktradesmoon Sep. 15 at 3:32 PM

$ABCL $ABCL YOUR Right about NO ONE Selling!! WRONG about the buying. 475,000 shares just bought in last 10-15 minutes. Look 👀 at LEVEL II.

1 · Reply

Samb2344 Sep. 15 at 3:31 PM

$ABCL we want $20-$30

0 · Reply

Market Cap	3.34B
Revenue (ttm)	75.13M
Net Income (ttm)	-146.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-194.88%
Debt to Equity Ratio	0.00

Volume	3,026,454
Avg Vol	7,116,102
Day's Range	N/A - N/A
Shares Out	306.61M
Stochastic %K	57%
Beta	1.32
Analysts	Strong Sell
Price Target	$17.12